Horizon Therapeutics Public Ltd Co Convertible Notes Payable, Noncurrent
Horizon Therapeutics Public Ltd Co had Convertible Notes Payable, Noncurrent of $356.55 million as of 2020-03-31, per its 10-Q filed 2020-05-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities › Notes Payable, Noncurrent
us-gaap:ConvertibleLongTermNotesPayable · last filed 2021-02-24
- 2020-03-31: Convertible Notes Payable, Noncurrent $356.55M.
- 2019-12-31: Convertible Notes Payable, Noncurrent $351.53M.
- 2019-09-30: Convertible Notes Payable, Noncurrent $346.54M.
- 2019-06-30: Convertible Notes Payable, Noncurrent $341.68M.
| Period end | Convertible Notes Payable, Noncurrent | Convertible Notes Payable, Noncurrent as first filed |
|---|---|---|
| 2020-03-31 | $356.55M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $351.53M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $346.54M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $341.68M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $336.86M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $332.20M 10-K · filed 2020-02-26 | |
| 2018-09-30 | $327.57M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $323.11M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $318.67M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $314.38M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $310.13M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $306.02M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $301.94M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $298.00M 10-K · filed 2018-02-28 | |
| 2016-09-30 | $294.09M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $290.31M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $286.56M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $282.89M 10-K · filed 2017-02-27 | $283.68M 10-K · filed 2016-02-29 |
| 2015-09-30 | $278.99M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $274.31M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $269.60M 10-Q · filed 2015-05-08 |